Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Serotonin sensitivity in insomnia: a placebo-controlled crossover study of sleep after 5HT2 blockade in primary insomnia
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN38174888
Date ISRCTN assigned28/09/2007
Local reference number(s)N0038183440
Public titleSerotonin sensitivity in insomnia: a placebo-controlled crossover study of sleep after 5HT2 blockade in primary insomnia
Scientific title
AcronymN/A
Disease/condition/study domainNervous System Diseases: Carpal tunnel decompression
Study hypothesisDoes Trazodone improve sleep in primary insomnia?
Design/methodologyPlacebo-controlled crossover study
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Adults referred to Psychopharmacology Unit Clinic 7, Bristol Royal Infirmary with psycho-physiological insomnia
2. Complaint of poor sleep with daytime consequences
Participants - exclusion criteria1. Taking psychotropic medication
2. Total sleep time (subjective) > 6.5 hours
3. Current psychiatric disorder
Patient information material
Anticipated start date28/04/2006
Anticipated end date31/01/2008
Status of trialCompleted
Target number of participants12 insomnia patients
InterventionsRCT: [A] trazodone; [B] placebo.
Randomised, double-blind, placebo-controlled crossover study.
Overnight sleep patterns recorded and compared, after either placebo or trazodone 100mg. Each patient has screening visit and 2 overnight sleep recordings at home a week apart, plus an end-of study visit.
Primary outcome measure(s)Sleep efficiency: % Total Sleep Time / Staging Time.
Secondary outcome measure(s)1. Daily symptom report (DSR)
2. Total sleep time (TST)
3. Number of awakenings
4. Wake Time After Sleep Onset (WASO)
5. Time spent in stages 1 to 4 and rapid eye movement (REM), %TST spent in each stage
6. REM onset latency
7. Sleep onset Latency (SOL), slow wave activity
8. Leeds Sleep Evaluation Questionnaire.
Sources of fundingAvon and Wiltshire Mental Health Partnership NHS Trust
AWP Partnership Mental Health NHS Trust R&D Project grant
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2007 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameDr Wilson Sue
Contact detailsUniversity of Bristol
Dorothy Hodgkin Building
Whitson Street

Bristol
United Kingdom
BS1 3NY
Contact telephone+44 0117 331 3172
Contact fax+44 0117 331 3180
Contact emailsue.wilson@bris.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN38174888
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central